e-z cinnamic acid has been researched along with Alloxan Diabetes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hafizur, MR; Jawaid, H; Khan, MI; Qureshi, U; Shah, SAR; Ul-Haq, Z | 1 |
| Nair, A; Preetha Rani, MR; Raghu, KG; Rajankutty, K; Ranjit, S; Salin Raj, P | 1 |
| Anlar, HG; Arı, N; Aydın, S; Bacanlı, M; Başaran, AA; Başaran, AN; Çal, T; Ündeğer Bucurgat, Ü | 1 |
| Chishti, S; Hafizur, RM; Hameed, A; Kabir, N; Raza, SA; Shukrana, M; Siddiqui, RA | 1 |
| Cao, X; Deng, W; Li, Q; Omari-Siaw, E; Wang, H; Wang, Q; Wang, S; Xu, X; Yu, J | 1 |
| Choung, SY; Kim, SH | 1 |
6 other study(ies) available for e-z cinnamic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Nicotinamide-cinnamic acid cocktail exerts pancreatic β-cells survival coupled with insulin secretion through ERK1/2 signaling pathway in an animal model of apoptosis.
Topics: Animals; Apoptosis; Blood Glucose; Cell Survival; Cinnamates; Diabetes Mellitus, Experimental; Gene Expression Regulation; Insulin Secretion; Insulin-Secreting Cells; Male; MAP Kinase Signaling System; Molecular Docking Simulation; Niacinamide; Rats; Streptozocin; Treatment Outcome | 2021 |
Cinnamic acid is beneficial to diabetic cardiomyopathy via its cardioprotective, anti-inflammatory, anti-dyslipidemia, and antidiabetic properties.
Topics: Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Hypoglycemic Agents; Male; Metformin; Rats; Rats, Wistar | 2022 |
Effects of cinnamic acid on complications of diabetes
Topics: Animals; Antioxidants; Catalase; Cinnamates; Diabetes Mellitus, Experimental; DNA Damage; Glutathione; Lipids; Liver; Malondialdehyde; Oxidative Stress; Phosphoric Monoester Hydrolases; Phytotherapy; Plant Extracts; Rats, Wistar; Superoxide Dismutase; Transferases | 2018 |
Cinnamic acid exerts anti-diabetic activity by improving glucose tolerance in vivo and by stimulating insulin secretion in vitro.
Topics: Acrolein; Animals; Blood Glucose; Cells, Cultured; Cinnamates; Diabetes Mellitus, Experimental; Female; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice, Inbred BALB C; Rats, Wistar | 2015 |
Self-nanoemulsifying drug delivery system of trans-cinnamic acid: formulation development and pharmacodynamic evaluation in alloxan-induced type 2 diabetic rat model.
Topics: Alloxan; Animals; Cinnamates; Diabetes Mellitus, Experimental; Drug Delivery Systems; Drug Design; Emulsifying Agents; Hypoglycemic Agents; Male; Nanocomposites; Rats; Rats, Wistar | 2015 |
Antihyperglycemic and antihyperlipidemic action of Cinnamomi Cassiae (Cinnamon bark) extract in C57BL/Ks db/db mice.
Topics: Abdominal Fat; Adiponectin; Animals; Blood Glucose; Body Weight; Cholesterol; Cinnamates; Cinnamomum; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Phytotherapy; Plant Bark; Plant Extracts; PPAR alpha; PPAR gamma; Triglycerides | 2010 |